Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.54 USD | +6.09% | +15.25% | +18.83% |
May. 20 | Pulse Biosciences Moves New Record Date for Rights Offering | MT |
May. 14 | Pulse Biosciences Appoints Burke Barrett as President, CEO | MT |
Financials (USD)
Sales 2022 | 0.7 | Sales 2023 | - | Capitalization | 674M |
---|---|---|---|---|---|
Net income 2022 | -58M | Net income 2023 | -42M | EV / Sales 2022 | 168,485,877 x |
Net Debt 2022 | 14.82M | Net cash position 2023 | 35.22M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.61
x | P/E ratio 2023 |
-13.9
x | Employees | 56 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.6% |
Latest transcript on Pulse Biosciences, Inc.
1 day | +6.09% | ||
1 week | +15.25% | ||
Current month | +25.93% | ||
1 month | +86.00% | ||
3 months | +58.62% | ||
6 months | +54.73% | ||
Current year | +18.83% |
Managers | Title | Age | Since |
---|---|---|---|
Burke T. Barrett
CEO | Chief Executive Officer | - | May. 11 |
Chief Tech/Sci/R&D Officer | - | 23-05-02 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 17-11-01 |
Director/Board Member | 46 | 17-11-01 | |
Darrin Uecker
CTO | Chief Tech/Sci/R&D Officer | 58 | 15-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.36% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +4.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 14.54 | +6.09% | 179,517 |
24-06-05 | 13.71 | -2.14% | 229,436 |
24-06-04 | 14.01 | +3.09% | 434,505 |
24-06-03 | 13.59 | +17.66% | 575,698 |
24-05-31 | 11.55 | -4.15% | 277,032 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+18.83% | 757M | |
+9.24% | 220B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.17B | |
+14.99% | 52.47B | |
+4.85% | 50.77B | |
-4.47% | 38.97B | |
-0.41% | 35.13B |
- Stock Market
- Equities
- PLSE Stock